MAPT and Parkinson disease: Two secondary aims were included: to examine whether levels of cNfH correlate with levels of CSF α-synuclein, amyloid-β (1-42) (Aβ42), phosphorylated tau at threonine 181 position (P-tau), total tau (T-tau), and magnetic resonance imaging measures; and to compare the associations between NfH, NfL, and clinical progression in the early stages of PD.